๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Off-label use of rituximab in systemic lupus erythematosus: a systematic review

โœ Scribed by Eleanor Murray; Martin Perry

Publisher
Springer
Year
2010
Tongue
English
Weight
189 KB
Volume
29
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Measurement of fatigue in systemic lupus
Measurement of fatigue in systemic lupus erythematosus: A systematic review
โœ Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 1 views

## Abstract ## Objective To systematically review fatigue instruments used in patients with systemic lupus erythematosus (SLE) and to seek consensus on which instruments should be recommended for future studies and which data on comorbid conditions should be reported when evaluating fatigue in pat

Efficacy and safety of rituximab in mode
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
โœ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 499 KB ๐Ÿ‘ 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p